
In human zzso cell lines zzso zzso and zzso zzso acid zzso at zzso zzso zzso readily zzso during zzso therapy with zzso zzso zzso zzso zzso zzso depletion leading to cell cycle arrest and zzso through a zzso zzso zzso zzso of zzso zzso and zzso and zzso of zzso and zzso zzso zzso is also associated to a marked decrease of zzso zzso In the same cell lines zzso at lower zzso zzso zzso corresponding to the plasma levels of the active free drug during zzso therapy, zzso differentiation toward the zzso zzso by causing a partial chronic zzso zzso zzso zzso differentiation is not associated to zzso zzso as occurs using zzso zzso At a fixed concentration of zzso a higher percentage of zzso or differentiated cells is obtained when non zzso serum zzso for the zzso one, due to the higher zzso concentration in the former (about 10 zzso leading to competition on zzso salvage of zzso At zzso or zzso zzso higher than 1 zzso (up to 100 zzso no further enhancement of zzso effects was zzso in agreement with the recently described safety of the zzso zzso combination in the treatment of zzso of kidney transplant zzso The zzso effects of zzso do not appear to be significantly increased by the zzso inhibitor zzso zzso 

